Shoot for the Moon: Joe Biden Launches a New Cancer Fight

Article

It should be no surprise that it took someone whose life was deeply impacted by the cancer experience to finally create a shift in how we approach a cure for this illness.

"And the goal of this initiative — this “Moonshot” — is to seize this moment. To accelerate our efforts to progress towards a cure, and to unleash new discoveries and breakthroughs for other deadly diseases." - Vice President Joe Biden

It should be no surprise that it took someone whose life was deeply impacted by the cancer experience to finally create a paradigm shift in how we approach a cure for this illness. As a pacifist in the war on cancer, I’m over the moon (pun intended) with the approach the vice president has outlined. The idea of marshaling our country’s resources and engaging the best and brightest in an all-out effort to cure cancer stands in stark contrast to the war mentality.

Our race into space and to put men on the moon was, arguably, one of our countries greatest accomplishments. Growing up a space baby, I was fascinated by the idea of meeting such a lofty goal. I was eight years old the day Neil Armstrong set foot on the moon and somewhere in our attic I still have the front page of the next day's newspaper. I have to wonder what would have happened if President Kennedy chose the battle theme for our quest. My guess is that if he had replaced “I believe that this nation should commit itself to achieving the goal, before this decade is out, of landing a man on the moon and returning him safely to the Earth” with declaring a “war on gravity,” we’d still be wondering if the moon is made of cheese.

If we look at the historical record of our success rates with our previous wars on poverty, drugs and terrorism, it seems that dislodging our efforts to cure cancer from that frame of mind would decrease the chance of failure. Wars are notorious for pouring valuable resources into bottomless wells where the original cause often gets lost amongst conflicting priorities. The moonshot analogy, on the other hand, speaks to a unified purpose and the coordination of resources toward a clearly defined target. Anyone who has ever watched a NASA-related movie knows, “Failure is not an option.” Now that’s the kind of boosting power we survivors have been dreaming of.

Of course, much like the original space race, the vice president’s plan has its naysayers. The New York Post put it this way: Biden’s cancer ‘moon shot’ is a grand idea that’s doomed. Others have jumped on the let’s-abort-the-launch bandwagon with explanations that run the gamut of the political spectrum.

I, for one, will not let these wet blankets dampen my enthusiasm for what could be a turning point. I prefer being associated with a pioneer in a space program than a soldier in a war. I love the idea that one giant leap for mankind in the search for a cure for cancer may mean many more small steps will be taken by millions of survivors around the globe.

To those who are already trying to point out the dark side of this new moonshot by suggesting that cancer is too complex and too difficult a disease to set such an unrealistic goal, I would remind them of President Kennedy’s words at the start of space race:

"We choose to go to the moon. We choose to go to the moon in this decade and do the other things, not because they are easy, but because they are hard, because that goal will serve to organize and measure the best of our energies and skills, because that challenge is one that we are willing to accept, one we are unwilling to postpone, and one which we intend to win, and the others, too."

Now that’s a battle cry to get behind. Let’s not wait another moment to shoot for the moon. In the words of the first American into space, Alan Shepard, let’s “light this candle.”

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content